Balance Sheets (USD $)	Jun. 30, 2013	Jun. 30, 2012
ASSETS
Cash	$ 41,180	$ 562
Accounts Receivable	25,119	3,370
Inventory	236,406	168,631
Prepaid Expenses	23,539	36,856
Total Current Assets	326,244	209,419
Property and Equipment
Computer Software	2,483	2,483
Computer Hardware	5,338	5,338
Equipment	2,136	2,136
Accumulated Depreciation	(5,090)	(2,805)
Net Property and Equipment	4,867	7,152
Other Assets
PuraMed Bioscience Products, net of accumulated amortization of $298,418 and $250,413, respectively	37,614	85,619
Trademarks, net of amortization of $2,754 and $1,139, respectively	13,383	14,998
Patents, net of amortization of $2,928 and $0, respectively	89,511	83,277
Deferred Financing Fees	4,727	0
Total Other Assets	145,235	183,894
Total Assets	476,346	400,465
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts Payable	627,427	359,785
Accrued Wages - Officers	435,326	155,628
Accrued Expenses	120,040	25,555
Short-term Term Note	525,000	0
Short-term Convertible Note, net of discount	454,025	43,941
Convertible bond payable, net of discount	598,733	449,510
Derivative Liability - Warrants	10,178	229,461
Derivative Liability - Convertible Debt	400,270	202,844
Total Current Liabilities	3,170,999	1,466,724
Long-term Liabilities
Conditionally Redeemable Stock	75,000	0
Commitments and Contingencies
Stockholders' Deficit
Undesignated shares, 5,000,000 shares authorized, none issued
Common Stock, $.001 par value, 1,000,000,000 shares authorized, 51,110,297 shares and 24,033,320 shares issued and outstanding, respectively	51,110	24,033
Additional paid in capital	5,528,469	4,696,336
Deficit Accumulated	(8,349,232)	(5,786,628)
Total Stockholders' Deficit	(2,694,653)	(1,066,259)
Total Liabilities and Stockholders' Deficit	$ 476,346	$ 400,465